CLDX vs COGT Stock Comparison

COGT currently leads CLDX in this stock comparison, with AIQ scores of 44 vs 43. The clearest difference is quality, while CLDX has the stronger risk resilience profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 1 points
CLDX
Healthcare
vs
COGT
Healthcare
CLDX
Celldex Therapeutics, Inc.
Price
$28.83
Day move
+1.05%
AIQ Score
43/100
Best edge
Risk Resilience
Sector
Healthcare
COGT
Cogent Biosciences, Inc.
Leads
Price
$28.56
Day move
-1.99%
AIQ Score
44/100
Best edge
Quality
Sector
Healthcare

What is the main difference between CLDX and COGT?

COGT leads the current stock comparison as Cogent Biosciences, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Celldex Therapeutics, Inc. vs Cogent Biosciences, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 59/66 fields· Moderate confidence
AIQ VerdictFragileAIQ Comparison Conviction 1/10

COGT leads

COGT leads by 1 AIQ points, primarily on Quality, having only recently taken the lead back from CLDX.

Fragile: 0 of 4 evidence groups support COGT, and the lead recently changed hands.

Evidence agreement: 0 of 4Comparison trend: Reversed
CLDX

Celldex Therapeutics, Inc.

AIQ Score
43/100
AIQ Edge Score
7/10
COGT

Cogent Biosciences, Inc.

Leads
AIQ Score
44/100
AIQ Edge Score
7/10

The Algovestiq AIQ Score currently favors COGT over CLDX, 44 versus 43 as of Nov 15, 2026. COGT's advantage is driven primarily by stronger quality, while CLDX holds the stronger risk resilience profile. COGT also shows the stronger technical structure relative to its 50-day moving average. 0 of 4 covered evidence groups favor COGT today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 1 points. COGT lead: Reversed — CLDX led by 2 AIQ points 30 sessions ago; COGT now leads by 1.

Compare Celldex Therapeutics, Inc. and Cogent Biosciences, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

CLDX
-34.2%
COGT
+164.2%

Price return comparison

Growth of $10,000, price only

CLDX $6,579 · COGT $26,420

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare CLDX and COGT against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

CLDX advantage
0
COGT advantage
  • Quality30 vs 40
    COGT +10
  • Risk Resilience55 vs 51
    CLDX +4
  • Momentum48 vs 45
    Even

0 of 4 evidence groups favor COGT. COGT’s edge is concentrated in quality; CLDX keeps a meaningful risk resilience edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

CLDX+2 AIQ

Largest factor move: Momentum +2

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.57x)
COGT+1 AIQ

Largest factor move: Momentum +3

New signals

  • 52-Week Low Proximity — bearish, risk_regime, long horizon (2.6%)

COGT's lead narrowed by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — CLDX and COGT both carry a full feed there.

The central trade-off

COGT (Cogent Biosciences, Inc.): the stronger current systematic profile, led by quality.

CLDX (Celldex Therapeutics, Inc.): the counter-case, on risk resilience, fundamentals, technicals.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

COGT

COGT on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

COGT

COGT on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

Even

The two are level on Momentum.

Lower downside

CLDX

CLDX on Risk Resilience, by 4 points.

Analyst upside

Even

Analyst targets are level or not covered for both names.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureCLDXCOGTNote
Implied upside to target+140.2%—Level
Target dispersion+44.8%—Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1512Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

0 of 4 covered evidence groups favor COGT. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreEven43 vs 44
FundamentalsCLDXEPS growth -2.1% vs -13.5%; TTM ROE -11.6% vs -21.6%
ValuationNot coveredNot covered
TechnicalsCLDXPrice vs 50-day -9.8% vs -9%; vs 200-day -12.2% vs -19.1%
Risk ResilienceCLDXRisk Resilience 55 vs 51
Analyst expectationsNot coveredNot covered

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of CLDX and COGT and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 1 points. (argues the conclusion is provisional)
  • Only 0 of 4 covered evidence groups agree. (argues the conclusion is provisional)
  • The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
  • The lead has been steady session to session. (supports the conclusion holding)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on COGT.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

COGT lead: Reversed — CLDX led by 2 AIQ points 30 sessions ago; COGT now leads by 1.

May 27CLDX leads above the line · COGT leads belowNov 13
Today
COGT +1
43 vs 44
7 sessions ago
COGT +2
41 vs 43
30 sessions ago
CLDX +2
42 vs 40
90 sessions ago
CLDX +7
62 vs 55

The lead changed hands 2 times in this window, most recently on Oct 30 when CLDX moved ahead of COGT.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

CLDX

0 bullish / 3 bearish / 1 neutral

Only CLDX

  • Low Volume Rally Warning — bearish, volume, short horizon (0.57x)
COGT

0 bullish / 4 bearish / 2 neutral

Only COGT

  • 52-Week Low Proximity — bearish, risk_regime, long horizon (2.6%)
  • ADX Trend Weakening — neutral, trend, medium horizon
  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon

Both carry 3 more signals that do not separate them: Death Cross Active, ATR Expansion - Breakout Mode, Downtrend Structure Active.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

CLDXConfirmed strength

Price and the AIQ Score both moved up over the latest session (price +1.05%, AIQ +2 points).

COGTDivergence

Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -1.99%, AIQ +1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1CLDX closes the Quality gap — currently 10 points behind, the largest single contributor to COGT's edge.
  2. 2CLDX's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3COGT starts generating bearish momentum or trend signals.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

CLDX leads on balance
MetricCLDXCOGT
Revenue growth (YoY)-100%0%
EPS growth (YoY)-2.1%-13.5%
Gross margin-6.6%0%
Operating margin-2986.6%0%
Return on equity (TTM)-11.6%-21.6%
Debt to equity0.020.47

Performance

CLDX leads 5 of 6 windows
MetricCLDXCOGT
1 week (5 sessions)-3.5%-9.7%
1 month (20 sessions)4.7%-3.3%
3 months (63 sessions)-31.2%-24.6%
6 months (126 sessions)-8%-12.6%
Year to date6.1%-19.6%
1 year (252 sessions)18.9%-19%

Technicals

CLDX has the stronger structure
MetricCLDXCOGT
RSI (14)43.540.8
ADX (14)17.117.5
Price vs 50-day-9.8%-9%
Price vs 200-day-12.2%-19.1%
Volatility (1M, annualized)54.4%62.1%

Risk

CLDX is the more resilient
MetricCLDXCOGT
Beta1.221.38
Sharpe ratio0.55-0.23
Sortino ratio0.88-0.33
Max drawdown-38.6%-34.4%
Current drawdown-35.7%-33.3%
Annualized volatility52.4%46%
Value at risk (95%)-4.9%-4.5%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, CLDX or COGT?

On the Algovestiq AIQ Score, COGT is the stronger of the two as of Nov 15, 2026, scoring 44 against CLDX's 43. The edge comes from quality. CLDX is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is CLDX or COGT the better buy right now?

COGT carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 0 of 4 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 1 points. Treat the lead as provisional.

Why does the AIQ Score favor COGT over CLDX?

The composite weights Quality, Value, Momentum and Risk Resilience. COGT leads Quality by 10 points; CLDX leads Risk Resilience by 4 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, CLDX or COGT?

Analyst price targets imply +140.2% upside for CLDX and not covered for COGT. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, CLDX or COGT?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, CLDX or COGT?

COGT on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, CLDX or COGT?

The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, CLDX or COGT?

CLDX is the more resilient of the two, so the other name carries the higher downside risk. CLDX on Risk Resilience, by 4 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is CLDX more profitable than COGT?

CLDX leads on the comparable margin measures — gross margin -6.6% vs 0%; operating margin -2986.6% vs 0%; ttm roe -11.6% vs -21.6%.

Is COGT's lead over CLDX getting stronger or weaker?

COGT lead: Reversed — CLDX led by 2 AIQ points 30 sessions ago; COGT now leads by 1. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 2 times in that window, most recently on 2026-10-30, when CLDX moved ahead of COGT.

What would change the CLDX vs COGT verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: CLDX closes the Quality gap — currently 10 points behind, the largest single contributor to COGT's edge; CLDX's Death Cross Active resolves — a bearish trend rule currently active against it; COGT starts generating bearish momentum or trend signals; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about CLDX and COGT?

CLDX: 0 bullish / 3 bearish / 1 neutral. COGT: 0 bullish / 4 bearish / 2 neutral. The most decision-relevant rule on CLDX is Death Cross Active (bearish, long horizon). On COGT it is Death Cross Active (bearish, long horizon).

Compare CLDX and COGT with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.